Cargando…
Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer?
OBJECTIVE: To explore the accuracy related to type and subtype between frozen section (FS) results and final pathology results in patients with endometrial cancer and to suggest whether it should be routinely performed. METHODS: Retrospective data were collected from 184 patients with endometrial ca...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290841/ https://www.ncbi.nlm.nih.gov/pubmed/33864253 http://dx.doi.org/10.1002/ijgo.13712 |
_version_ | 1784749004018417664 |
---|---|
author | Guo, Qingyong Yi, Huan Chen, Xiaodan Song, Jianrong Chen, Lingsi Zheng, Xiangqin |
author_facet | Guo, Qingyong Yi, Huan Chen, Xiaodan Song, Jianrong Chen, Lingsi Zheng, Xiangqin |
author_sort | Guo, Qingyong |
collection | PubMed |
description | OBJECTIVE: To explore the accuracy related to type and subtype between frozen section (FS) results and final pathology results in patients with endometrial cancer and to suggest whether it should be routinely performed. METHODS: Retrospective data were collected from 184 patients with endometrial cancer who underwent surgery at a single center (January 2014–December 2018). FS results were compared with the final pathology results with respect to histotype, tumor grade, and depth of invasion to define the accuracy of FS analysis. RESULTS: Frozen section analysis was performed in 141 (76.6%) patients. The accuracy rates and κ values between the FS and final pathology results with respect to histotype, tumor grade, and depth of invasion were 87.23%, 81.15%, and 98.2% and 0.41, 0.7, and 0.9, respectively (P < 0.001). Among the 18 patients with preoperative non‐endometrioid cancer (non‐EC), six underwent FS analysis, and final pathology confirmed EC in three, of whom 75% were detected by FS analysis. Eight of 19 patients with preoperative grade 3 EC underwent FS analysis and the accuracy rate was 87.5%. CONCLUSION: Intraoperative FS analysis is a reliable method that can help intraoperative decision making. It should be performed routinely in patients with non‐EC and grade 3 EC. |
format | Online Article Text |
id | pubmed-9290841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92908412022-07-20 Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? Guo, Qingyong Yi, Huan Chen, Xiaodan Song, Jianrong Chen, Lingsi Zheng, Xiangqin Int J Gynaecol Obstet Clinical Articles OBJECTIVE: To explore the accuracy related to type and subtype between frozen section (FS) results and final pathology results in patients with endometrial cancer and to suggest whether it should be routinely performed. METHODS: Retrospective data were collected from 184 patients with endometrial cancer who underwent surgery at a single center (January 2014–December 2018). FS results were compared with the final pathology results with respect to histotype, tumor grade, and depth of invasion to define the accuracy of FS analysis. RESULTS: Frozen section analysis was performed in 141 (76.6%) patients. The accuracy rates and κ values between the FS and final pathology results with respect to histotype, tumor grade, and depth of invasion were 87.23%, 81.15%, and 98.2% and 0.41, 0.7, and 0.9, respectively (P < 0.001). Among the 18 patients with preoperative non‐endometrioid cancer (non‐EC), six underwent FS analysis, and final pathology confirmed EC in three, of whom 75% were detected by FS analysis. Eight of 19 patients with preoperative grade 3 EC underwent FS analysis and the accuracy rate was 87.5%. CONCLUSION: Intraoperative FS analysis is a reliable method that can help intraoperative decision making. It should be performed routinely in patients with non‐EC and grade 3 EC. John Wiley and Sons Inc. 2021-05-12 2022-02 /pmc/articles/PMC9290841/ /pubmed/33864253 http://dx.doi.org/10.1002/ijgo.13712 Text en © 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Clinical Articles Guo, Qingyong Yi, Huan Chen, Xiaodan Song, Jianrong Chen, Lingsi Zheng, Xiangqin Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? |
title | Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? |
title_full | Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? |
title_fullStr | Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? |
title_full_unstemmed | Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? |
title_short | Is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? |
title_sort | is routine frozen section analysis necessary in patients with non‐endometrioid cancer or grade 3 endometrioid cancer? |
topic | Clinical Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290841/ https://www.ncbi.nlm.nih.gov/pubmed/33864253 http://dx.doi.org/10.1002/ijgo.13712 |
work_keys_str_mv | AT guoqingyong isroutinefrozensectionanalysisnecessaryinpatientswithnonendometrioidcancerorgrade3endometrioidcancer AT yihuan isroutinefrozensectionanalysisnecessaryinpatientswithnonendometrioidcancerorgrade3endometrioidcancer AT chenxiaodan isroutinefrozensectionanalysisnecessaryinpatientswithnonendometrioidcancerorgrade3endometrioidcancer AT songjianrong isroutinefrozensectionanalysisnecessaryinpatientswithnonendometrioidcancerorgrade3endometrioidcancer AT chenlingsi isroutinefrozensectionanalysisnecessaryinpatientswithnonendometrioidcancerorgrade3endometrioidcancer AT zhengxiangqin isroutinefrozensectionanalysisnecessaryinpatientswithnonendometrioidcancerorgrade3endometrioidcancer |